Original language | English |
---|---|
Pages (from-to) | 160S-160S |
Journal | Journal of clinical oncology |
Volume | 23 |
Issue number | 16 |
Publication status | Published - 1 Jun 2005 |
A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.
J Voortman, EF Smit, BC Kuenen, HM Pinedo, C van Groeningen, AJ van den Eertwegh, D Brouwer, H van de Velde, G Giaccone
Research output: Contribution to journal › Meeting Abstract › Academic